Highlights,AEON Biopharma implements 1-for-72 reverse stock split to maintain NYSE compliance.,New split ratio approved by stockholders at February 24 meeting.,Fractional shares rounded up to the ...
Stocktwits on MSN11d
AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last WeekAIM ImmunoTech surged in retail discussions after announcing the first new subject was dosed in Phase 2 of its Phase 1b/2 ...
The Reverse Stock Split will take legal effect at 12:01 A.M. Eastern Time on February 26, 2025, and the Company's Common Stock will open for trading on the NYSE American on February 26, 2025, on a ...
AEON Biopharma, Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351 (k) biosimilar pathway, today announced that ...
(RTTNews) - AEON Biopharma, Inc. (AEON), a clinical-stage biopharmaceutical company, announced that its Board of Directors has approved a 1-for-72 reverse stock split of its common stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback